Clinical Bioenergetics (notice n° 1322021)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 02455cam a2200277zu 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | FRCYB88962665 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250429180317.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 250429s2020 fr | o|||||0|0|||eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780128196212 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | FRCYB88962665 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | FR-PaCSA |
Language of cataloging | en |
Transcribing agency | |
Description conventions | rda |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ostojic, Sergej M. |
245 01 - TITLE STATEMENT | |
Title | Clinical Bioenergetics |
Remainder of title | From Pathophysiology to Clinical Translation |
Statement of responsibility, etc. | ['Ostojic, Sergej M.'] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Name of producer, publisher, distributor, manufacturer | Academic Press |
Date of production, publication, distribution, manufacture, or copyright notice | 2020 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | p. |
336 ## - CONTENT TYPE | |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type code | c |
Source | rdamdedia |
338 ## - CARRIER TYPE | |
Carrier type code | c |
Source | rdacarrier |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Clinical Bioenergetics: From Pathophysiology to Clinical Translation provides recent developments surrounding the etiology and pathophysiology of inherited and acquired energy-delated disorders. Across 40 chapters, world leaders in bioenergetics and mitochondrial medicine discuss novel methodologies designed to identify deficiencies in cellular bioenergetics, as well as the safety and efficacy of emerging management strategies to address poor cellular bioenergetics. Topics discussed include the omics landscape of impaired mitochondrial bioenergetics, hormones, tissue bioenergetics and metabolism in humans. Disease-specific case studies, modes of analysis in clinical bioenergetics, and therapeutic opportunities for impaired bioenergetics, addressing both known treatment pathways and future directions for research, are discussed in-depth. Diseases and Disorders examined include brain injury, chronic fatigue syndrome, psychiatric disorders, pulmonary fibrosis, neurodegenerative disorders, heart failure, chronic kidney disease, obesity, and insulin resistance, among others. - Provides a thorough discussion of foundational aspects of bioenergetics and disease, modes of analysis, and treatments for impaired bioenergetics - Discusses the role of bioenergetics and treatment pathways in brain injury, chronic fatigue syndrome, psychiatric disorders, pulmonary fibrosis, neurodegenerative disorders, heart failure, chronic kidney disease, obesity, and insulin resistance, among other diseases and disorders - Features chapter contributions from international leaders in translational bioenergetics research and clinical practice |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | |
700 0# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ostojic, Sergej M. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Access method | Cyberlibris |
Uniform Resource Identifier | <a href="https://international.scholarvox.com/netsen/book/88962665">https://international.scholarvox.com/netsen/book/88962665</a> |
Electronic format type | text/html |
Host name |
Pas d'exemplaire disponible.
Réseaux sociaux